Please join us for Episode Two of the NACD New England Chapter Private Company Governance and Leadership Series. Our panelists include currently serving Directors and C-Suite executives, who will discuss issues unique to private companies, and their decision to remain private.
Topics will include the patient capital, corporate culture, control, freedom from quarterly financial pressure, less regulation and other aspects of the allure of being a private company. Speakers include Elizabeth Boland, CFO from Bright Horizons which went from Public to Private and back again; and Directors and Executives of several private companies. Our moderator, Jim Wood, is from the EY Family Enterprise Business Services Group.
About Our Panel:
Elizabeth J. Boland is the Chief Financial Officer and Treasurer of Bright Horizons, the leading provider of early child care education and other services designed to help employers, working parents and adult learners better address the challenges of work and family life. In addition to operating more than 1,000 child care centers in the US, UK and the Netherlands, Bright Horizons provides intermittent back-up child care and elder care for working families, and educational advising services for adult learners.
Ms. Boland joined Bright Horizons prior to its original IPO in 1997, and has managed financial strategy, capital markets, investor relations and financial operations for the Company as it has grown to nearly $2 billion in annual revenue and $7 billion market cap. After a leveraged buy-out by Bain Capital in 2008, Ms. Boland had the unique experience of taking Bright Horizons public a second time in 2013. Ms. Boland started her career at PricewaterhouseCoopers and is a CPA. Professor Fred Foulkes received M.B.A. and D.B.A. degrees from Harvard Business School and an A.B., magna cum laude, Phi Beta Kappa, from Princeton University. He taught at HBS before joining the faculty at Boston University.
His principal publications include: Creating More Meaningful Work (AMA); Personnel Policies in Large Nonunion Companies (Prentice-Hall); Human Resources Management: Cases and Text (with E.R. Livernash, Prentice-Hall); Executive Compensation: A Strategic Guide for the 1990s (HBS Press). Professor Foulkes has also written numerous articles, including five published in the Harvard Business Review, two published in Directors and Boards, and has developed over 160 case studies.
Professor Foulkes is the founder and director of the Human Resources Policy Institute, a partnership between Questrom School of Business faculty and over 45 chief HR officers of many of the largest companies in the US, including: Colgate, CVS Health, Fidelity, HP, IBM, P&G and Raytheon.
Recipient of the Employment Management Association Award and the Five Star Achievement Award from the Northeast Human Resources Association, Professor Foulkes is a Fellow of the National Academy of Human Resources (NAHR), the human resources profession’s highest honor for outstanding achievement.
A former Director of Panera Bread where he was on the audit committee and chair of the compensation committee, he is a Director of Operation ABLE and a member of the NAHR Foundation Board. Over the past 20 years, Professor Foulkes has been a Director of three private companies, 3 public companies, and seven non-profits, including being a trustee of Wheelock College.
Halley Gilbert, Esquire is Senior Vice President & Chief Legal Officer at Ironwood Pharmaceuticals, Inc. She joined Ironwood in 2008 as the founding member of its legal department, establishing the company’s legal and compliance functions as Ironwood grew from a privately-held, research-based organization to a publicly-traded, fully-integrated commercial biotechnology company. Ms. Gilbert is one of four Section 16 Officers at Ironwood and serves on the company’s strategic investments and operating committees. Ms. Gilbert has two decades of experience navigating biopharmaceutical companies through transformational change, as well as expertise in corporate development, corporate governance, and the operational and legal issues relevant to launching new medicines into specialty and primary care markets. Prior to joining Ironwood, Halley was Vice President, Deputy General Counsel at Cubist Pharmaceuticals, Inc. from 2002 to 2008, where she supported the launch of Cubist’s first acute care antibiotic, and she served as Corporate Counsel at Genzyme Corp. from 1999 to 2001. Halley began her career at Skadden, Arps, Slate, Meagher & Flom LLP, where she specialized in mergers and acquisitions and securities law.
Ms. Gilbert serves on the Board of Directors of Achaogen, Inc., a publicly-traded clinical-stage biopharmaceutical company focused on the development of novel antibacterials, and is a member of Achaogen’s Audit, Nominating & Governance, and Transaction Committees. Ms. Gilbert also serves on the boards of directors of Allergy Amulet, Inc., a venture capital backed allergy device company, Greater Boston Legal Services, a not-for-profit that provides free legal services to Boston residents in need and is on the Advisory Board of Life Science Cares, a not-for-profit focused on eliminating the impact of poverty on the Greater Boston community. Ms. Gilbert is also the Chair of the General Counsel Committee of BIO, a trade organization that represents the biotechnology industry. Ms. Gilbert holds a J.D. from Northwestern University School of Law and a B.A. from Tufts University.
About Our Moderator: Jim Wood is an executive director in Ernst & Young’s Family Enterprise Business Services, an advisory practice working exclusively with multi-generational family business owners to grow and transition larger and more valuable companies. He is a practice leader in the areas of family and business governance, generational transition and growth strategy development.
Jim has over 26 years of experience in business strategy and the family business space having held roles as advisor, Board Member, and senior executive in a family-held business. Prior to EY, he spent 15 years as Sr. Vice President and Chief Strategy Officer for a 3rd generation family business where he led significant growth, diversification and margin expansion initiatives. He has also served on several privately-held and family business Boards, with leadership roles on audit, compensation and strategic alternatives committees. He is author of the book, “The Next Level: Essential Strategies for Achieving Breakthrough Growth.”